Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: A case report

Elizabeth M. O'brien, Peter B. Rosenquist, James N. Kimball, Gregory N. Dunn, Bryan Smith, Lorraine M. Arias

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an α2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.

Original languageEnglish (US)
Pages (from-to)131-133
Number of pages3
JournalJournal of ECT
Volume26
Issue number2
DOIs
StatePublished - Jun 1 2010
Externally publishedYes

Fingerprint

Dexmedetomidine
Electroconvulsive Therapy
Medical Staff

Keywords

  • Dexmedetomidine
  • ECT
  • Morbid obesity
  • Postictal agitation
  • Sedation
  • α2 agonist

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Psychiatry and Mental health

Cite this

Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation : A case report. / O'brien, Elizabeth M.; Rosenquist, Peter B.; Kimball, James N.; Dunn, Gregory N.; Smith, Bryan; Arias, Lorraine M.

In: Journal of ECT, Vol. 26, No. 2, 01.06.2010, p. 131-133.

Research output: Contribution to journalArticle

O'brien, Elizabeth M. ; Rosenquist, Peter B. ; Kimball, James N. ; Dunn, Gregory N. ; Smith, Bryan ; Arias, Lorraine M. / Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation : A case report. In: Journal of ECT. 2010 ; Vol. 26, No. 2. pp. 131-133.
@article{de03caa35692464c86345a7e7a8a1b07,
title = "Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: A case report",
abstract = "Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an α2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.",
keywords = "Dexmedetomidine, ECT, Morbid obesity, Postictal agitation, Sedation, α2 agonist",
author = "O'brien, {Elizabeth M.} and Rosenquist, {Peter B.} and Kimball, {James N.} and Dunn, {Gregory N.} and Bryan Smith and Arias, {Lorraine M.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1097/YCT.0b013e3181b07c26",
language = "English (US)",
volume = "26",
pages = "131--133",
journal = "Journal of ECT",
issn = "1095-0680",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation

T2 - A case report

AU - O'brien, Elizabeth M.

AU - Rosenquist, Peter B.

AU - Kimball, James N.

AU - Dunn, Gregory N.

AU - Smith, Bryan

AU - Arias, Lorraine M.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an α2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.

AB - Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an α2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.

KW - Dexmedetomidine

KW - ECT

KW - Morbid obesity

KW - Postictal agitation

KW - Sedation

KW - α2 agonist

UR - http://www.scopus.com/inward/record.url?scp=77953153587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953153587&partnerID=8YFLogxK

U2 - 10.1097/YCT.0b013e3181b07c26

DO - 10.1097/YCT.0b013e3181b07c26

M3 - Article

C2 - 19710618

AN - SCOPUS:77953153587

VL - 26

SP - 131

EP - 133

JO - Journal of ECT

JF - Journal of ECT

SN - 1095-0680

IS - 2

ER -